To analyse whether Dexmedetomidine(Central Alpha 2 Agonist) can be used safely as a sedative/analgesic agent In patients undergoing Laparoscopic Tubal Ligation And with/without MTP
Not Applicable
Completed
- Conditions
- Health Condition 1: null- FEMALE PATIENTS SCHEDULED FOR LAPAROSCOPIC TUBAL LIGATION WITH MEDICAL TERMINATION OF PREGNANCY
- Registration Number
- CTRI/2017/11/010353
- Lead Sponsor
- ALL INDIA INSTITUTE OF MEDICAL SCIENCES
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
1. Patients(ASA I and II) scheduled for laparoscopic interval tubal ligation with MTP under local anesthesia(procedure time 15 TO 30 minutes)
Exclusion Criteria
1. Not willing to participate
2. patient having local anesthetic hypersensitivity
3. patients With uncontrolled co morbid condition
4. Inadequate fasting
BMI>=35
concurrent surgeries
difficult airway
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. tolerance and comfort of the patients during uterine evacuation and laparoscopic tubal ligation performed under local anesthesia. <br/ ><br>2. pain scores after laparoscopic tubal ligation with uterine evacuation. <br/ ><br>Timepoint: 1.during the procedure and post operatively every 15 minutes and sos till the patient is discharged
- Secondary Outcome Measures
Name Time Method adverse effects like hypotension, bradycardia during the procedure and post op PONV, sedation <br/ ><br>2.discharge readinessof the patient <br/ ><br>3. patient satisfaction score and surgeons copmfort scoreTimepoint: 1.intraoperatively <br/ ><br>2. post operatively every 15 minutes and sos till the patient is discharged